by Women’s health apps provide a convenient way for women to track their menstrual cycles and fertility windows, monitor their overall wellness, and address other women’s health concerns like pregnancy and childbirth. These apps incorporate artificial intelligence (AI) and machine learning capabilities to analyse data patterns and provide personalized insights and predictions to users. The use of AI helps apps to be more intuitive and accurate with features like cycle tracking, period and ovulation prediction, pregnancy tracking, hormonal changes monitoring, and fertility planning.
The global Women Health App Market is estimated to be valued at US$ 3.14 Bn in 2023 and is expected to exhibit a CAGR of 6.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
AI capabilities allow apps to understand individual women’s cycles and patterns over time based on the data provided and make personalized predictions. For example, cycle tracking apps using AI get more accurate at predicting periods and fertility windows as more cycle data is recorded. Similarly, pregnancy and fertility planning apps are able to provide tailored insight and guidance to each user based on her medical history, lifestyle factors, and ongoing biometric data analyzed using machine learning algorithms. AI engines continuously learn from large data sets and identify subtle patterns to enhance user experience of women’s health apps. This rising integration of advanced technologies like AI is expected to boost the demand for intuitive and customized women’s health apps.
Segment Analysis
In the global Women Health App market, the fertility tracker segment is dominating currently holding over 35% share of the overall market. The high adoption of fertility tracker apps among women to track menstrual cycle and monitor ovulation periods on a monthly basis is supporting the growth of this segment. These apps help women trying to conceive get pregnant faster by predicting the fertile window.
Key Takeaways
The Global Women Health App Market Size is expected to witness high growth over the forecast period between 2023 to 2030 at a CAGR of 6.9%. The market size is projected to reach US$ 3.14 Bn by 2024.
Regional analysis: North America currently dominates the global Women Health App market with over 40% share, driven by the availability of advanced digital tools and high women health awareness in countries like US and Canada. Asia Pacific is expected to witness the fastest growth over the coming years, supported by improving access to smartphones and increasing acceptance of women healthcare technology in developing countries like China and India.
Key players operating in the Women Health App market are Thermo Fisher Scientific Inc., Merck KGaA, Novozymes A/S, QIAGEN N.V., Promega Corporation, Agilent Technologies, Inc., New England Biolabs, Inc., Takara Bio Inc., Bio-Rad Laboratories, Inc. and GenScript Biotech Corporation.
Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
